Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2025-09-18 00:00:00 ET · period of report 2025-09-16 · accession 0001610717-25-000351 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2025-09-18 | 2025-09-16 | RVMD | Wei Lin | Chief Medical Off | S - Sale | $45.82 | -2,160 | 88.3K | -2% | -$99.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-16 | S | D | 2,160 | $45.82 | 88,339 | D | — | — | (F2) Includes 58,850 restricted stock units. |